Articles by Disease (Rheumatoid Arthritis)

Laboratory Biomarkers for Guiding Therapy with Methotrexate in Rheumatoid Arthritis

Journal: Current Pharmaceutical Design
Volume: 21
Page: 202-211
Author(s): Carlos Abud-Mendoza, Marco U. Martínez-Martínez, Adriana Monsivais-Urenda and Roberto Gonzalez- Amaro

Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 21
Page: 182-201
Author(s): Luis Rodriguez-Rodriguez, Raquel López-Mejias, Benjamín Fernández-Gutiérrez, Alejandro Balsa, Miguel A. González-Gay and Javier Martín

Role of T Lymphocytes in the Development of Rheumatoid Arthritis. Implications for Treatment

Journal: Current Pharmaceutical Design
Volume: 21
Page: 142-146
Author(s): Erik Lubberts

Editorial (Thematic Issue: Optimizing Treatment in Rheumatoid Arthritis)

Journal: Current Pharmaceutical Design
Volume: 21
Page: 129-129
Author(s): Rosa P. Gomariz and Isidoro Gonzalez-Alvaro

Predictors of Response to TNF Antagonists

Journal: Current Pharmaceutical Design
Volume: 21
Page: 221-232
Author(s): Eva Salgado, Jose Ramon Maneiro and Juan J. Gomez-Reino

Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion

Journal: Current Pharmaceutical Design
Volume: 21
Page: 233-240
Author(s): MJ Garcia de Yebenes, E Loza and L Carmona

Are Patient Self-Report Questionnaires as "Scientific" as Biomarkers in "Treat-totarget" and Prognosis in Rheumatoid Arthritis?

Journal: Current Pharmaceutical Design
Volume: 21
Page: 241-256
Author(s): Theodore Pincus and Isabel Castrejon